
Dermatologicals in Lithuania
Description
Dermatologicals in Lithuania
Dermatologicals is posting robustly positive current value growth in Lithuania in 2024, that is more impressive than that of some other consumer health categories. Still, as is the case across much of the industry, growth is largely generated by rising prices rather than higher volume sales.
Euromonitor International's Dermatologicals in Lithuania report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Table of Contents
22 Pages
- Dermatologicals in Lithuania
- Euromonitor International
- October 2024
- List Of Contents And Tables
- DERMATOLOGICALS IN LITHUANIA
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Convincing performance from dermatologicals in 2024
- Female-oriented products and topical antifungals gain ground
- Multinationals continue to lead, leaving little space for local players
- PROSPECTS AND OPPORTUNITIES
- Little change anticipated for dermatologicals
- Cold sore treatments will continue to expand but vaginal antifungals has reached its peak
- Out-of-home habits to support topical antiseptics while hair loss sales will benefit from innovation
- CATEGORY DATA
- Table 1 Sales of Dermatologicals by Category: Value 2019-2024
- Table 2 Sales of Dermatologicals by Category: % Value Growth 2019-2024
- Table 3 NBO Company Shares of Dermatologicals: % Value 2020-2024
- Table 4 LBN Brand Shares of Dermatologicals: % Value 2021-2024
- Table 5 Forecast Sales of Dermatologicals by Category: Value 2024-2029
- Table 6 Forecast Sales of Dermatologicals by Category: % Value Growth 2024-2029
- CONSUMER HEALTH IN LITHUANIA
- EXECUTIVE SUMMARY
- Consumer health in 2024: The big picture
- 2024 key trends
- Competitive landscape
- Retailing developments
- What next for consumer health?
- MARKET INDICATORS
- Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
- Table 8 Life Expectancy at Birth 2019-2024
- MARKET DATA
- Table 9 Sales of Consumer Health by Category: Value 2019-2024
- Table 10 Sales of Consumer Health by Category: % Value Growth 2019-2024
- Table 11 NBO Company Shares of Consumer Health: % Value 2020-2024
- Table 12 LBN Brand Shares of Consumer Health: % Value 2021-2024
- Table 13 Penetration of Private Label by Category: % Value 2019-2024
- Table 14 Distribution of Consumer Health by Format: % Value 2019-2024
- Table 15 Distribution of Consumer Health by Format and Category: % Value 2024
- Table 16 Forecast Sales of Consumer Health by Category: Value 2024-2029
- Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
- APPENDIX
- OTC registration and classification
- Vitamins and dietary supplements registration and classification
- Self-medication/self-care and preventive medicine
- Switches
- DISCLAIMER
- DEFINITIONS
- SOURCES
- Summary 1 Research Sources
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.